Outcomes of early inhaled nitric oxide use in premature African American neonates

Christopher A. Collura, Kristin C. Mara, Amy L. Weaver, Reese H. Clark, William A Carey

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: Meta-analysis of individual-patient clinical trial data suggests that inhaled nitric oxide (iNO) improves respiratory outcomes in premature African American neonates. We hypothesized that early iNO therapy would be associated with lower mortality and less chronic lung disease (CLD) in extremely premature African American neonates. Study design: We conducted a retrospective cohort study of propensity score- and race-matched neonates 22–29 weeks gestation who were mechanically ventilated for treatment of respiratory distress and associated pulmonary hypertension (RDS + PPHN). We evaluated the association of iNO within 7 days of life with in-hospital mortality and CLD, using Cox proportional hazards regression and logistic regression, respectively. Result: Among 178 matched pairs of African American patients, iNO was not associated with lower mortality (HR = 0.94, 95% CI 0.69–1.30) or less CLD (OR = 0.94, 95% CI 0.47–1.87). Conclusions: Early, off-label iNO use is not associated with improved outcomes in premature African American neonates with RDS + PPHN.

Original languageEnglish (US)
Pages (from-to)1657-1665
Number of pages9
JournalJournal of Perinatology
Volume38
Issue number12
DOIs
StatePublished - Dec 1 2018

Fingerprint

African Americans
Nitric Oxide
Newborn Infant
Lung Diseases
Chronic Disease
Propensity Score
Mortality
Hospital Mortality
Pulmonary Hypertension
Meta-Analysis
Cohort Studies
Retrospective Studies
Logistic Models
Clinical Trials
Pregnancy
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Collura, C. A., Mara, K. C., Weaver, A. L., Clark, R. H., & Carey, W. A. (2018). Outcomes of early inhaled nitric oxide use in premature African American neonates. Journal of Perinatology, 38(12), 1657-1665. https://doi.org/10.1038/s41372-018-0232-6

Outcomes of early inhaled nitric oxide use in premature African American neonates. / Collura, Christopher A.; Mara, Kristin C.; Weaver, Amy L.; Clark, Reese H.; Carey, William A.

In: Journal of Perinatology, Vol. 38, No. 12, 01.12.2018, p. 1657-1665.

Research output: Contribution to journalArticle

Collura, CA, Mara, KC, Weaver, AL, Clark, RH & Carey, WA 2018, 'Outcomes of early inhaled nitric oxide use in premature African American neonates', Journal of Perinatology, vol. 38, no. 12, pp. 1657-1665. https://doi.org/10.1038/s41372-018-0232-6
Collura, Christopher A. ; Mara, Kristin C. ; Weaver, Amy L. ; Clark, Reese H. ; Carey, William A. / Outcomes of early inhaled nitric oxide use in premature African American neonates. In: Journal of Perinatology. 2018 ; Vol. 38, No. 12. pp. 1657-1665.
@article{e7bd0b98cd444ba8b5b0e809df76ce98,
title = "Outcomes of early inhaled nitric oxide use in premature African American neonates",
abstract = "Objective: Meta-analysis of individual-patient clinical trial data suggests that inhaled nitric oxide (iNO) improves respiratory outcomes in premature African American neonates. We hypothesized that early iNO therapy would be associated with lower mortality and less chronic lung disease (CLD) in extremely premature African American neonates. Study design: We conducted a retrospective cohort study of propensity score- and race-matched neonates 22–29 weeks gestation who were mechanically ventilated for treatment of respiratory distress and associated pulmonary hypertension (RDS + PPHN). We evaluated the association of iNO within 7 days of life with in-hospital mortality and CLD, using Cox proportional hazards regression and logistic regression, respectively. Result: Among 178 matched pairs of African American patients, iNO was not associated with lower mortality (HR = 0.94, 95{\%} CI 0.69–1.30) or less CLD (OR = 0.94, 95{\%} CI 0.47–1.87). Conclusions: Early, off-label iNO use is not associated with improved outcomes in premature African American neonates with RDS + PPHN.",
author = "Collura, {Christopher A.} and Mara, {Kristin C.} and Weaver, {Amy L.} and Clark, {Reese H.} and Carey, {William A}",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41372-018-0232-6",
language = "English (US)",
volume = "38",
pages = "1657--1665",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Outcomes of early inhaled nitric oxide use in premature African American neonates

AU - Collura, Christopher A.

AU - Mara, Kristin C.

AU - Weaver, Amy L.

AU - Clark, Reese H.

AU - Carey, William A

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Objective: Meta-analysis of individual-patient clinical trial data suggests that inhaled nitric oxide (iNO) improves respiratory outcomes in premature African American neonates. We hypothesized that early iNO therapy would be associated with lower mortality and less chronic lung disease (CLD) in extremely premature African American neonates. Study design: We conducted a retrospective cohort study of propensity score- and race-matched neonates 22–29 weeks gestation who were mechanically ventilated for treatment of respiratory distress and associated pulmonary hypertension (RDS + PPHN). We evaluated the association of iNO within 7 days of life with in-hospital mortality and CLD, using Cox proportional hazards regression and logistic regression, respectively. Result: Among 178 matched pairs of African American patients, iNO was not associated with lower mortality (HR = 0.94, 95% CI 0.69–1.30) or less CLD (OR = 0.94, 95% CI 0.47–1.87). Conclusions: Early, off-label iNO use is not associated with improved outcomes in premature African American neonates with RDS + PPHN.

AB - Objective: Meta-analysis of individual-patient clinical trial data suggests that inhaled nitric oxide (iNO) improves respiratory outcomes in premature African American neonates. We hypothesized that early iNO therapy would be associated with lower mortality and less chronic lung disease (CLD) in extremely premature African American neonates. Study design: We conducted a retrospective cohort study of propensity score- and race-matched neonates 22–29 weeks gestation who were mechanically ventilated for treatment of respiratory distress and associated pulmonary hypertension (RDS + PPHN). We evaluated the association of iNO within 7 days of life with in-hospital mortality and CLD, using Cox proportional hazards regression and logistic regression, respectively. Result: Among 178 matched pairs of African American patients, iNO was not associated with lower mortality (HR = 0.94, 95% CI 0.69–1.30) or less CLD (OR = 0.94, 95% CI 0.47–1.87). Conclusions: Early, off-label iNO use is not associated with improved outcomes in premature African American neonates with RDS + PPHN.

UR - http://www.scopus.com/inward/record.url?scp=85054354428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054354428&partnerID=8YFLogxK

U2 - 10.1038/s41372-018-0232-6

DO - 10.1038/s41372-018-0232-6

M3 - Article

C2 - 30275545

AN - SCOPUS:85054354428

VL - 38

SP - 1657

EP - 1665

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 12

ER -